ArticleBMC infectious diseases2026
Using interpretable machine learning to analyze the trajectory changes of serum albumin to predict the mortality rate of sepsis: a cohort study based on MIMIC-IV.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlthough hypoalbuminemia at ICU admission is associated with increased in-hospital mortality in septic patients, the prognostic value of serum albumin trajectory changes based on repeated measurements remains unclear. This study aimed to identify longitudinal serum albumin trajectory changes, evaluate their association with clinical outcomes at different temporal windows, and construct interpretable machine learning (ML) models for risk prediction.
methodsUsing the MIMIC-IV v3.0 database, trajectory analysis (via the traje R package) classified serum albumin trajectory changes into three groups: Persistently Low, Persistently Moderate, and Persistently High. Kaplan-Meier survival curves and Cox regression models were employed to analyze associations between trajectory groups and ICU, 28-day, and 90-day mortality. The Boruta algorithm screened feature variables, and seven ML models (XGBoost, SVM, LightGBM, RandomForest, e.g.) were developed. Model performance was evaluated using ROC curves, and SHapley Additive exPlanations (SHAP) values provided interpretability. A nomogram was constructed for clinical utility.
resultsAmong 1,714 included patients, trajectory groups comprised Persistently Low (n = 477), Persistently Moderate (n = 749), and Persistently High (n = 488). Multivariable Cox regression (fully adjusted Model 3) revealed that compared to the Persistently Low group, both the Persistently High group and Persistently Moderate group exhibited significantly lower 28-day mortality risk (HR = 0.72, 95% CI: 0.56-0.93 for High; HR = 0.77, 95% CI: 0.61-0.96 for Moderate) and 90-day mortality risk (HR = 0.74, 95% CI: 0.60-0.92 for High; HR = 0.72, 95% CI: 0.60-0.87). For ML predictions, LightGBM achieved optimal AUCs for ICU mortality (0.758) and 28-day mortality (0.753), while RandomForest performed best for 90-day mortality (AUC = 0.721). SHAP analysis ranked serum albumin trajectories as the third most critical predictor for 90-day mortality. The nomogram showed good discrimination for 90-day mortality prediction, with an AUC of 0.765, and the calibration curve suggested acceptable agreement between predicted and observed risks.
conclusionSerum albumin trajectory changes in sepsis were associated with mortality outcomes at different time windows. In the fully adjusted Cox models, these trajectory changes remained significantly associated with 28-day and 90-day all-cause mortality, whereas their association with ICU mortality was attenuated after comprehensive adjustment. The integrated machine learning framework, particularly LightGBM and RandomForest, provides clinicians with interpretable tools for prognosis stratification in patients with sepsis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.